Diamyd Logo
This website is only intended for investors

Fighting diabetes

Diamyd Medical is a diabetes company active in the field of pharmaceutical development. The Company is headquartered in Stockholm, Sweden and shares are listed on Nasdaq Stockholm First North (ticker: DMYD B).
We expect several new studies to start recruiting participants in the first quarter of 2015.
Diabetes is associated with serious complications due to elevated and fluctuating blood sugar levels, causing substantial suffering and extensive costs for society.
Following an intense autumn with many positives, Diamyd Medical was able to start the New Year with yet more good news. On January 6, 2015, the United States Patent and Trademark Office granted a new...
Diamyd® is a GAD-based therapy under development for the treatment and prevention of autoimmune diabetes such as type 1 diabetes and LADA. Treatment with Diamyd® aims to intervene in the autoimmune...
rss icon
pdf icon
21 januari 2015, 08:30
Delårsrapport I 14/15